Adalimumab Biosimilar-Induced Severe Paradoxical Palmoplantar Pustulosis in a Patient with Psoriasis and Psoriatic Arthritis Successfully Treated with Ixekizumab
Author:
Publisher
Springer Science and Business Media LLC
Subject
Dermatology
Link
https://link.springer.com/content/pdf/10.1007/s13555-021-00672-z.pdf
Reference15 articles.
1. Parisi R, Iskandar IYK, Kontopantelis E, et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590.
2. Armstrong AW, Soliman AM, Betts KA, et al. Comparative efficacy and relative ranking of biologics and oral therapies for moderate-to-severe plaque psoriasis: a network meta-analysis. Dermatol Ther (Heidelb). 2021;11(3):885–905.
3. Wendling D, Prati C. Paradoxical effects of anti-TNF-α agents in inflammatory diseases. Expert Rev Clin Immunol. 2014;10(1):159–69.
4. Puig L, Gulliver W. Adverse reactions to biologics. In: Puig L, Gulliver W, editors. Adverse reactions to biologics. Current problems in dermatology, vol 53. Basel: Karger; 2018. p. 49–63
5. Zangrilli A, Bavetta M, Mazzilli S, Garofalo V, Bianchi L. Paradoxical case effects of psoriasis following adalimumab therapy: a case series. Dermatol Ther. 2018;31(6):e12729.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options;Journal of Investigative Dermatology;2024-07
2. Local injection of micro-dose anti-interleukin-17A antibody for palmoplantar pustulosis: A real-world study;Clinical Immunology;2023-08
3. Deficiency of interleukin‐36 receptor antagonist (DITRA): An analysis of 58 Chinese patients in a tertiary hospital in Taiwan;Experimental Dermatology;2023-03-07
4. Adalimumab-induced palmoplantar pustulosis in a patient with inflammatory bowel disease;CosmoDerma;2022-07-25
5. Recalcitrant and persistent adalimumab‐induced paradoxical psoriasiform skin reaction in a rheumatoid arthritis patient successfully treated with upadacitinib;Dermatologic Therapy;2022-07-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3